Ligand Pharmaceuticals Inc. (LGND) is a publicly traded Healthcare sector company. As of May 21, 2026, LGND trades at $217.75 with a market cap of $4.17B and a P/E ratio of 27.80. LGND moved +4.88% today. Year to date, LGND is +13.39%; over the trailing twelve months it is +107.54%. Its 52-week range spans $93.58 to $247.38. Analyst consensus is strong buy with an average price target of $279.71. Rallies surfaces LGND's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for LGND combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $217.75 |
| Market Cap | $4.17B |
| P/E Ratio | 27.80 |
| EPS | $7.90 |
| Dividend Yield | 0.08% |
| 52-Week High | $247.38 |
| 52-Week Low | $93.58 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $274.48M |
| Net Income | $153.56M |
| Gross Margin | 0.00% |
7 analysts cover LGND: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $279.71.